Related Experiment Video
Updated: Aug 16, 2026

09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?
Myron Schwartz1, Sasan Roayaie, Josep Llovet
1Recanati-Miller Transplantation Institute, Mount Sinai School of Medicine, New York, USA. myron.schwartz@mssm.edu
Journal of Hepatology
|August 27, 2005
Abstract
No abstract available in PubMed .
